Disciplined Investments, LLC Viatris Inc Transaction History

Disciplined Investments, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 10, 2023	SELL	$9.02 - $10.29 $793 - $905	-88 Reduced 35.77%	158 $1,000
Q1 2023 May 10, 2023	BUY	$9.2 - $12.26 $9 - $12	1 Added 0.41%	246 $2,000
Q4 2022 Feb 01, 2023	SELL	$8.72 - $11.56 $148 - $196	-17 Reduced 6.49%	245 $2,000
Q3 2022 Nov 03, 2022	SELL	$8.48 - $11.13 $152 - $200	-18 Reduced 6.43%	262 $2,000
Q2 2022 Aug 09, 2022	BUY	$9.95 - $12.27 $1,800 - $2,220	181 Added 182.83%	280 $3,000
Q1 2022 Apr 22, 2022	SELL	$9.81 - $15.4 $7,073 - $11,103	-721 Reduced 87.93%	99 $1,000
Q4 2020 Feb 12, 2021	BUY	$14.3 - $18.74 $11,726 - $15,366	820 New	820 $15,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Disciplined Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Disciplined Investments, LLC with notifications on news.